RecruitingNot Applicable

Triage - Symptoms and Other Predictors in an All-comer Emergency Department Population

Switzerland6,467 participantsStarted 2022-05-17

Plain-language summary

This study is to evaluate a tool capable of improved risk prediction regarding the 30-day mortality. The primary objective of this study is hospitalization, ICU-admission, morbidity and mortality in correlation with external validation of International Early Warning Score (IEWS) and decision-making processes regarding diagnosis, treatment and disposition in the ED.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients presenting to the ED of the University Hospital Basel over a timecourse of 9 weeks in 2022, 2024, 2026 Exclusion Criteria: * Obstetric, ophthalmologic, and paediatric patients will not be included * unwillingness to participate * insufficient ability to communicate with the study personnel.

What they're measuring

30-day mortality

Timeframe: within 30 days of the day of presentation to the ED

Trial details

NCT IDNCT05400707

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-27

Contact for this trial

Roland Bingisser, Prof. Dr. med.

+41 61 265 58 30 roland.bingisser@usb.ch

View on ClinicalTrials.gov More Triage Risk Stratification trials